Detalhe da pesquisa
1.
Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer.
Oncologist
; 29(4): 342-349, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38207008
2.
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 18(12): 1610-1623, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129443
3.
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508).
Cancer
; 122(15): 2371-8, 2016 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27163943
4.
A New Standard of Care for Advanced Lung Cancer.
N Engl J Med
; 378(22): 2135-2137, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29847766
5.
Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508).
Cancer
; 121(13): 2253-61, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25740387
6.
Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancer.
Invest New Drugs
; 32(1): 123-34, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23579358
7.
Stigma among patients with lung cancer: a patient-reported measurement model.
Psychooncology
; 23(1): 81-92, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24123664
8.
An eHealth system supporting palliative care for patients with non-small cell lung cancer: a randomized trial.
Cancer
; 119(9): 1744-51, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23355273
9.
Air Pollution and Lung Cancer: A Review by International Association for the Study of Lung Cancer Early Detection and Screening Committee.
J Thorac Oncol
; 18(10): 1277-1289, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277094
10.
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline.
J Clin Oncol
; 40(28): 3310-3322, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816666
11.
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
J Clin Oncol
; 40(28): 3323-3343, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35816668
12.
Anti-EGFR monoclonal antibodies in lung cancer treatment.
Lancet Oncol
; 16(7): 738-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26045341
13.
The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer.
JTO Clin Res Rep
; 2(7): 100194, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34590039
14.
Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial.
J Thorac Oncol
; 16(6): 960-967, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539971
15.
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
J Clin Oncol
; 39(9): 1040-1091, 2021 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33591844
16.
New molecularly targeted therapies for lung cancer.
J Clin Invest
; 117(10): 2740-50, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17909619
17.
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503.
Invest New Drugs
; 28(1): 91-7, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19238328
18.
Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508).
Clin Lung Cancer
; 21(6): 520-526, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32807654
19.
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
J Clin Oncol
; 38(14): 1608-1632, 2020 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31990617
20.
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer.
Clin Cancer Res
; 26(2): 364-372, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31540980